Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bortezomib prevents oncogenesis and bone metastasis of prostate cancer by inhibiting WWP1, Smurf1 and Smurf2
Zhiyu Wang, Juan Wang, Xing Li, et al.
International Journal of Oncology (2014) Vol. 45, Iss. 4, pp. 1469-1478
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Molecular functions of NEDD4 E3 ubiquitin ligases in cancer
Xiao Ping Zou, Gal Levy‐Cohen, Michael Blank
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2015) Vol. 1856, Iss. 1, pp. 91-106
Closed Access | Times Cited: 107
The functions and regulation of Smurfs in cancers
Lin Fu, Chun‐Ping Cui, Xueli Zhang, et al.
Seminars in Cancer Biology (2019) Vol. 67, pp. 102-116
Open Access | Times Cited: 89
Mechanisms, Diagnosis and Treatment of Bone Metastases
Jozef Ban, Valerie Fock, Dave N.T. Aryee, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2944-2944
Open Access | Times Cited: 64
Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer
Yusuke Goto, Satoko Kojima, Akira Kurozumi, et al.
British Journal of Cancer (2016) Vol. 114, Iss. 10, pp. 1135-1144
Open Access | Times Cited: 61
Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration
Farjana Yeasmin Khusbu, Xi Zhou, Mridul Roy, et al.
The International Journal of Biochemistry & Cell Biology (2019) Vol. 118, pp. 105644-105644
Closed Access | Times Cited: 59
The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment
Yijie Wang, Xiong Liu, Weixiao Huang, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108303-108303
Closed Access | Times Cited: 30
Bortezomib attenuates renal interstitial fibrosis in kidney transplantation via regulating the EMT induced by TNF‐α‐Smurf1‐Akt‐mTOR‐P70S6K pathway
Jiajun Zhou, Hong Cheng, Zijie Wang, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 8, pp. 5390-5402
Open Access | Times Cited: 50
WWP1 E3 ligase at the crossroads of health and disease
Abhayananda Behera, Aramati B. M. Reddy
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 14
NEDD4 E3 ubiquitin ligases: Promising biomarkers and therapeutic targets for cancer
Xianyan Tian, Yifei Chen, Ziluo Peng, et al.
Biochemical Pharmacology (2023) Vol. 214, pp. 115641-115641
Closed Access | Times Cited: 13
The role of WWP1 and WWP2 in bone/cartilage development and diseases
Yanzhuang Wang, Zuping Wu, Cunyi Wang, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 5
RETRACTED ARTICLE: IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way
Xiang Zhang, Dawei Wang, Boke Liu, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 34
The emerging role of WWP1 in cancer development and progression
Xiaoli Hu, Jiangtao Yu, Zixia Lin, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 32
Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges
Peng Ye, Xiaoxia Chi, Jong‐Ho Cha, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3309-3309
Open Access | Times Cited: 30
Expression of SMURF family in pancreatic cancer and its effect on cell proliferation and migration
Chen Zhang, Chenqi Li, Lingfei Wu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Cross-ancestry meta-genome-wide association studies provide insights to the understanding of semen traits in pigs
Hong Cheng, Zhiyuan Zhang, H. Han, et al.
animal (2024) Vol. 18, Iss. 11, pp. 101331-101331
Open Access | Times Cited: 3
SMURF1, a promoter of tumor cell progression?
Xia Qin, Yang Li, Da Han, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 6, pp. 551-565
Closed Access | Times Cited: 27
The role ofSMURFsin non‐cancerous diseases
Dong Wang, Yuanming Zou, Xinyue Huang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 8
Open Access | Times Cited: 7
The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment
Di Zhang, Guilian Yang, Lei Zhang, et al.
Recent Patents on Anti-Cancer Drug Discovery (2021) Vol. 17, Iss. 3, pp. 268-283
Closed Access | Times Cited: 16
The Proteasome and Myeloma-Associated Bone Disease
Fabrizio Accardi, Denise Toscani, Federica Costa, et al.
Calcified Tissue International (2017) Vol. 102, Iss. 2, pp. 210-226
Closed Access | Times Cited: 20
Bortezomib Rescues Ovariectomy-Induced Bone Loss via SMURF-Mediated Ubiquitination Pathway
Yuepeng Fang, Yang Liu, Zhijian Zhao, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 15
Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer
Kunal Chaudhary, Connor J. Kinslow, Haiying Cheng, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Suppression of the Smurf1 Expression Inhibits Tumor Progression in Gliomas
Hao Chang, Jingning Zhang, Zengli Miao, et al.
Cellular and Molecular Neurobiology (2017) Vol. 38, Iss. 2, pp. 421-430
Closed Access | Times Cited: 17
PSMA5 promotes the tumorigenic process of prostate cancer and is related to bortezomib resistance
Zhenrui Fu, Chao Lü, Changwen Zhang, et al.
Anti-Cancer Drugs (2019) Vol. 30, Iss. 7, pp. 722-730
Closed Access | Times Cited: 17
Divergent Modulation of Proteostasis in Prostate Cancer
Petek Ballar, Burcu Erbaykent Tepedelen, Oğuz Gözen, et al.
Advances in experimental medicine and biology (2020), pp. 117-151
Closed Access | Times Cited: 15
SMAD specific E3 ubiquitin protein ligase�1 promotes ovarian cancer cell migration and invasion via the activation of the RhoA/ROCK signaling pathway
Wei Wang, Han Du, Huiping Liu, et al.
Oncology Reports (2018)
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top